|
LACTB2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.320300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.123700E-02 |
| Normal-vs-Stage2 |
5.952400E-01 |
| Normal-vs-Stage3 |
3.915800E-01 |
| Normal-vs-Stage4 |
2.754000E-01 |
| Stage1-vs-Stage2 |
6.023600E-02 |
| Stage1-vs-Stage3 |
6.629600E-01 |
| Stage1-vs-Stage4 |
4.133800E-01 |
| Stage2-vs-Stage3 |
2.708800E-01 |
| Stage2-vs-Stage4 |
2.127200E-01 |
| Stage3-vs-Stage4 |
9.467400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.653500E-02 |
| Normal-vs-AfricanAmerican |
2.937000E-01 |
| Normal-vs-Asian |
6.321400E-01 |
| Caucasian-vs-AfricanAmerican |
9.898400E-01 |
| Caucasian-vs-Asian |
8.953000E-01 |
| AfricanAmerican-vs-Asian |
8.956200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.473150E-01 |
| Normal-vs-Female |
9.709600E-02 |
| Male-vs-Female |
8.321800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.538800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.083030E-01 |
| Normal-vs-Age(61-80Yrs) |
2.004000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.680000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.623400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.713000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.580600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.176000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.182000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.536000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.435000E-04 |
| Normal-vs-Grade 2 |
3.721800E-01 |
| Normal-vs-Grade 3 |
2.692600E-01 |
| Normal-vs-Grade 4 |
1.516230E-03 |
| Grade 1-vs-Grade 2 |
1.572120E-02 |
| Grade 1-vs-Grade 3 |
6.063200E-03 |
| Grade 1-vs-Grade 4 |
4.903600E-01 |
| Grade 2-vs-Grade 3 |
9.974600E-01 |
| Grade 2-vs-Grade 4 |
4.323700E-02 |
| Grade 3-vs-Grade 4 |
1.237870E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.331400E-01 |
| Normal-vs-ccB subtype |
2.307600E-01 |
| ccA subtype-vs-ccB subtype |
5.939800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.607200E-01 |
| Normal-vs-N1 |
9.562400E-01 |
| N0-vs-N1 |
8.098800E-01 |
|
|
